nodes	percent_of_prediction	percent_of_DWPC	metapath
Medroxyprogesterone Acetate—HSD3B2—type 2 diabetes mellitus	0.26	0.552	CbGaD
Medroxyprogesterone Acetate—SHBG—type 2 diabetes mellitus	0.0748	0.159	CbGaD
Medroxyprogesterone Acetate—AR—type 2 diabetes mellitus	0.0656	0.139	CbGaD
Medroxyprogesterone Acetate—NR3C1—type 2 diabetes mellitus	0.0445	0.0945	CbGaD
Medroxyprogesterone Acetate—CYP3A4—type 2 diabetes mellitus	0.0258	0.0548	CbGaD
Medroxyprogesterone Acetate—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.0232	0.0758	CbGbCtD
Medroxyprogesterone Acetate—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.0186	0.0606	CbGbCtD
Medroxyprogesterone Acetate—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.0168	0.0548	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0162	0.0529	CbGbCtD
Medroxyprogesterone Acetate—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.0155	0.0506	CbGbCtD
Medroxyprogesterone Acetate—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.015	0.0488	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0148	0.0484	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0138	0.045	CbGbCtD
Medroxyprogesterone Acetate—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.0122	0.0398	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0117	0.0382	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0117	0.0382	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0108	0.0353	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0106	0.0345	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0104	0.0341	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Valsartan—type 2 diabetes mellitus	0.00954	0.0312	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00941	0.0307	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00887	0.029	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00861	0.0281	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.0085	0.0278	CbGbCtD
Medroxyprogesterone Acetate—CYP2C8—Losartan—type 2 diabetes mellitus	0.00786	0.0257	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00753	0.0246	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00681	0.0222	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00599	0.0196	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Losartan—type 2 diabetes mellitus	0.00548	0.0179	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00516	0.0168	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00494	0.0161	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00494	0.0161	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00468	0.0153	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00348	0.0114	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Losartan—type 2 diabetes mellitus	0.00319	0.0104	CbGbCtD
Medroxyprogesterone Acetate—SHBG—hindlimb—type 2 diabetes mellitus	0.00207	0.125	CbGeAlD
Medroxyprogesterone Acetate—AR—penis—type 2 diabetes mellitus	0.00196	0.119	CbGeAlD
Medroxyprogesterone Acetate—PGR—artery—type 2 diabetes mellitus	0.00114	0.0693	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—islet of Langerhans—type 2 diabetes mellitus	0.000809	0.0491	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—nerve—type 2 diabetes mellitus	0.000653	0.0396	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—nephron tubule—type 2 diabetes mellitus	0.000652	0.0396	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—pancreas—type 2 diabetes mellitus	0.000569	0.0345	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—cortex of kidney—type 2 diabetes mellitus	0.000558	0.0339	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—adipose tissue—type 2 diabetes mellitus	0.000516	0.0313	CbGeAlD
Medroxyprogesterone Acetate—SHBG—cardiovascular system—type 2 diabetes mellitus	0.00044	0.0267	CbGeAlD
Medroxyprogesterone Acetate—PGR—cardiovascular system—type 2 diabetes mellitus	0.000396	0.0241	CbGeAlD
Medroxyprogesterone Acetate—SHBG—adipose tissue—type 2 diabetes mellitus	0.000388	0.0236	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—liver—type 2 diabetes mellitus	0.000362	0.022	CbGeAlD
Medroxyprogesterone Acetate—PGR—adipose tissue—type 2 diabetes mellitus	0.000349	0.0212	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—islet of Langerhans—type 2 diabetes mellitus	0.000316	0.0192	CbGeAlD
Medroxyprogesterone Acetate—AR—cardiovascular system—type 2 diabetes mellitus	0.000316	0.0192	CbGeAlD
Medroxyprogesterone Acetate—ESR1—cardiovascular system—type 2 diabetes mellitus	0.00031	0.0188	CbGeAlD
Medroxyprogesterone Acetate—AR—kidney—type 2 diabetes mellitus	0.000309	0.0188	CbGeAlD
Medroxyprogesterone Acetate—ESR1—kidney—type 2 diabetes mellitus	0.000303	0.0184	CbGeAlD
Medroxyprogesterone Acetate—AR—cortex of kidney—type 2 diabetes mellitus	0.000301	0.0183	CbGeAlD
Medroxyprogesterone Acetate—Cyproterone acetate—AR—type 2 diabetes mellitus	0.0003	0.0886	CrCbGaD
Medroxyprogesterone Acetate—AR—adipose tissue—type 2 diabetes mellitus	0.000278	0.0169	CbGeAlD
Medroxyprogesterone Acetate—ESR1—adipose tissue—type 2 diabetes mellitus	0.000273	0.0166	CbGeAlD
Medroxyprogesterone Acetate—SHBG—liver—type 2 diabetes mellitus	0.000272	0.0165	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—nephron tubule—type 2 diabetes mellitus	0.000255	0.0155	CbGeAlD
Medroxyprogesterone Acetate—CYP2C8—kidney—type 2 diabetes mellitus	0.00025	0.0152	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—cardiovascular system—type 2 diabetes mellitus	0.000229	0.0139	CbGeAlD
Medroxyprogesterone Acetate—CYP2C9—cardiovascular system—type 2 diabetes mellitus	0.000227	0.0138	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—kidney—type 2 diabetes mellitus	0.000224	0.0136	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—pancreas—type 2 diabetes mellitus	0.000222	0.0135	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—cortex of kidney—type 2 diabetes mellitus	0.000218	0.0132	CbGeAlD
Medroxyprogesterone Acetate—Cyproterone acetate—NR3C1—type 2 diabetes mellitus	0.000204	0.0601	CrCbGaD
Medroxyprogesterone Acetate—NR3C1—adipose tissue—type 2 diabetes mellitus	0.000202	0.0122	CbGeAlD
Medroxyprogesterone Acetate—AR—liver—type 2 diabetes mellitus	0.000195	0.0119	CbGeAlD
Medroxyprogesterone Acetate—ESR1—liver—type 2 diabetes mellitus	0.000192	0.0116	CbGeAlD
Medroxyprogesterone Acetate—CYP3A4—kidney—type 2 diabetes mellitus	0.000169	0.0103	CbGeAlD
Medroxyprogesterone Acetate—CYP2C8—liver—type 2 diabetes mellitus	0.000158	0.00959	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—liver—type 2 diabetes mellitus	0.000141	0.00859	CbGeAlD
Medroxyprogesterone Acetate—CYP2C9—liver—type 2 diabetes mellitus	0.00014	0.00852	CbGeAlD
Medroxyprogesterone Acetate—Prednicarbate—NR3C1—type 2 diabetes mellitus	0.000131	0.0387	CrCbGaD
Medroxyprogesterone Acetate—Drospirenone—AR—type 2 diabetes mellitus	0.000125	0.037	CrCbGaD
Medroxyprogesterone Acetate—Fludrocortisone—AR—type 2 diabetes mellitus	0.000118	0.0348	CrCbGaD
Medroxyprogesterone Acetate—Fluoxymesterone—SHBG—type 2 diabetes mellitus	0.000111	0.0328	CrCbGaD
Medroxyprogesterone Acetate—Medrysone—NR3C1—type 2 diabetes mellitus	0.00011	0.0325	CrCbGaD
Medroxyprogesterone Acetate—CYP3A4—liver—type 2 diabetes mellitus	0.000107	0.0065	CbGeAlD
Medroxyprogesterone Acetate—Flurandrenolide—NR3C1—type 2 diabetes mellitus	0.000106	0.0313	CrCbGaD
Medroxyprogesterone Acetate—Testosterone Propionate—AR—type 2 diabetes mellitus	0.000105	0.031	CrCbGaD
Medroxyprogesterone Acetate—Hydrocortamate—NR3C1—type 2 diabetes mellitus	0.000103	0.0303	CrCbGaD
Medroxyprogesterone Acetate—Spironolactone—SHBG—type 2 diabetes mellitus	0.000102	0.03	CrCbGaD
Medroxyprogesterone Acetate—Cortisone acetate—NR3C1—type 2 diabetes mellitus	0.000101	0.0298	CrCbGaD
Medroxyprogesterone Acetate—Fluoxymesterone—AR—type 2 diabetes mellitus	9.75e-05	0.0288	CrCbGaD
Medroxyprogesterone Acetate—Megestrol acetate—NR3C1—type 2 diabetes mellitus	9.73e-05	0.0287	CrCbGaD
Medroxyprogesterone Acetate—Methyltestosterone—SHBG—type 2 diabetes mellitus	8.97e-05	0.0265	CrCbGaD
Medroxyprogesterone Acetate—Spironolactone—AR—type 2 diabetes mellitus	8.92e-05	0.0263	CrCbGaD
Medroxyprogesterone Acetate—Fludrocortisone—NR3C1—type 2 diabetes mellitus	8e-05	0.0236	CrCbGaD
Medroxyprogesterone Acetate—Spironolactone—ABCC2—type 2 diabetes mellitus	7.94e-05	0.0234	CrCbGaD
Medroxyprogesterone Acetate—Methyltestosterone—AR—type 2 diabetes mellitus	7.87e-05	0.0232	CrCbGaD
Medroxyprogesterone Acetate—Fluorometholone—NR3C1—type 2 diabetes mellitus	7.71e-05	0.0228	CrCbGaD
Medroxyprogesterone Acetate—Methylprednisolone—NR3C1—type 2 diabetes mellitus	7.46e-05	0.022	CrCbGaD
Medroxyprogesterone Acetate—Testosterone—CYP11A1—type 2 diabetes mellitus	7.39e-05	0.0218	CrCbGaD
Medroxyprogesterone Acetate—Hydrocortisone—SHBG—type 2 diabetes mellitus	6.76e-05	0.0199	CrCbGaD
Medroxyprogesterone Acetate—Fluoxymesterone—NR3C1—type 2 diabetes mellitus	6.61e-05	0.0195	CrCbGaD
Medroxyprogesterone Acetate—Spironolactone—NR3C1—type 2 diabetes mellitus	6.05e-05	0.0179	CrCbGaD
Medroxyprogesterone Acetate—Hydrocortamate—CYP3A4—type 2 diabetes mellitus	5.95e-05	0.0175	CrCbGaD
Medroxyprogesterone Acetate—Cortisone acetate—CYP3A4—type 2 diabetes mellitus	5.85e-05	0.0173	CrCbGaD
Medroxyprogesterone Acetate—Progesterone—SHBG—type 2 diabetes mellitus	5.51e-05	0.0162	CrCbGaD
Medroxyprogesterone Acetate—Testosterone—SHBG—type 2 diabetes mellitus	5.21e-05	0.0154	CrCbGaD
Medroxyprogesterone Acetate—Eplerenone—CYP3A4—type 2 diabetes mellitus	5.14e-05	0.0152	CrCbGaD
Medroxyprogesterone Acetate—Progesterone—AR—type 2 diabetes mellitus	4.83e-05	0.0142	CrCbGaD
Medroxyprogesterone Acetate—Drospirenone—PTGS2—type 2 diabetes mellitus	4.82e-05	0.0142	CrCbGaD
Medroxyprogesterone Acetate—Testosterone—AR—type 2 diabetes mellitus	4.56e-05	0.0135	CrCbGaD
Medroxyprogesterone Acetate—Fluorometholone—CYP3A4—type 2 diabetes mellitus	4.47e-05	0.0132	CrCbGaD
Medroxyprogesterone Acetate—Methylprednisolone—CYP3A4—type 2 diabetes mellitus	4.32e-05	0.0128	CrCbGaD
Medroxyprogesterone Acetate—Myalgia—Irbesartan—type 2 diabetes mellitus	4.09e-05	0.000317	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Metformin—type 2 diabetes mellitus	4.09e-05	0.000317	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Orlistat—type 2 diabetes mellitus	4.08e-05	0.000316	CcSEcCtD
Medroxyprogesterone Acetate—Malaise—Losartan—type 2 diabetes mellitus	4.08e-05	0.000316	CcSEcCtD
Medroxyprogesterone Acetate—Anxiety—Irbesartan—type 2 diabetes mellitus	4.08e-05	0.000316	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Glyburide—type 2 diabetes mellitus	4.08e-05	0.000316	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Metformin—type 2 diabetes mellitus	4.08e-05	0.000316	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Metformin—type 2 diabetes mellitus	4.07e-05	0.000315	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Valsartan—type 2 diabetes mellitus	4.07e-05	0.000315	CcSEcCtD
Medroxyprogesterone Acetate—Vertigo—Losartan—type 2 diabetes mellitus	4.06e-05	0.000315	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	4.06e-05	0.000315	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	4.06e-05	0.000315	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Valsartan—type 2 diabetes mellitus	4.06e-05	0.000315	CcSEcCtD
Medroxyprogesterone Acetate—Syncope—Losartan—type 2 diabetes mellitus	4.06e-05	0.000314	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Orlistat—type 2 diabetes mellitus	4.05e-05	0.000314	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Irbesartan—type 2 diabetes mellitus	4.04e-05	0.000313	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Metformin—type 2 diabetes mellitus	4.04e-05	0.000313	CcSEcCtD
Medroxyprogesterone Acetate—Immune system disorder—Ramipril—type 2 diabetes mellitus	4.02e-05	0.000312	CcSEcCtD
Medroxyprogesterone Acetate—Hydrocortisone—NR3C1—type 2 diabetes mellitus	4.02e-05	0.0119	CrCbGaD
Medroxyprogesterone Acetate—Hyperhidrosis—Metformin—type 2 diabetes mellitus	4.02e-05	0.000311	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Valsartan—type 2 diabetes mellitus	4.02e-05	0.000311	CcSEcCtD
Medroxyprogesterone Acetate—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	4.02e-05	0.000311	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Bromocriptine—type 2 diabetes mellitus	4e-05	0.00031	CcSEcCtD
Medroxyprogesterone Acetate—Dry mouth—Irbesartan—type 2 diabetes mellitus	4e-05	0.00031	CcSEcCtD
Medroxyprogesterone Acetate—Palpitations—Losartan—type 2 diabetes mellitus	4e-05	0.00031	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Glimepiride—type 2 diabetes mellitus	3.98e-05	0.000309	CcSEcCtD
Medroxyprogesterone Acetate—Loss of consciousness—Losartan—type 2 diabetes mellitus	3.98e-05	0.000308	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Sitagliptin—type 2 diabetes mellitus	3.97e-05	0.000308	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Orlistat—type 2 diabetes mellitus	3.97e-05	0.000308	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Glyburide—type 2 diabetes mellitus	3.97e-05	0.000308	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Valsartan—type 2 diabetes mellitus	3.97e-05	0.000308	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Metformin—type 2 diabetes mellitus	3.96e-05	0.000307	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Gliclazide—type 2 diabetes mellitus	3.95e-05	0.000306	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	3.94e-05	0.000305	CcSEcCtD
Medroxyprogesterone Acetate—Alopecia—Ramipril—type 2 diabetes mellitus	3.94e-05	0.000305	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Valsartan—type 2 diabetes mellitus	3.93e-05	0.000305	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Gliclazide—type 2 diabetes mellitus	3.93e-05	0.000304	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Gliclazide—type 2 diabetes mellitus	3.93e-05	0.000304	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	3.92e-05	0.000304	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Irbesartan—type 2 diabetes mellitus	3.92e-05	0.000304	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Orlistat—type 2 diabetes mellitus	3.92e-05	0.000304	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Glyburide—type 2 diabetes mellitus	3.91e-05	0.000303	CcSEcCtD
Medroxyprogesterone Acetate—Mental disorder—Ramipril—type 2 diabetes mellitus	3.9e-05	0.000303	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Valsartan—type 2 diabetes mellitus	3.9e-05	0.000303	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Irbesartan—type 2 diabetes mellitus	3.9e-05	0.000302	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	3.89e-05	0.000302	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Orlistat—type 2 diabetes mellitus	3.89e-05	0.000301	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Metformin—type 2 diabetes mellitus	3.88e-05	0.000301	CcSEcCtD
Medroxyprogesterone Acetate—Erythema—Ramipril—type 2 diabetes mellitus	3.88e-05	0.000301	CcSEcCtD
Medroxyprogesterone Acetate—Malnutrition—Ramipril—type 2 diabetes mellitus	3.88e-05	0.000301	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Irbesartan—type 2 diabetes mellitus	3.86e-05	0.000299	CcSEcCtD
Medroxyprogesterone Acetate—Arthralgia—Losartan—type 2 diabetes mellitus	3.85e-05	0.000299	CcSEcCtD
Medroxyprogesterone Acetate—Chest pain—Losartan—type 2 diabetes mellitus	3.85e-05	0.000299	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Losartan—type 2 diabetes mellitus	3.85e-05	0.000299	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Bromocriptine—type 2 diabetes mellitus	3.85e-05	0.000298	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	3.85e-05	0.000298	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	3.84e-05	0.000298	CcSEcCtD
Medroxyprogesterone Acetate—Anxiety—Losartan—type 2 diabetes mellitus	3.84e-05	0.000297	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Irbesartan—type 2 diabetes mellitus	3.83e-05	0.000297	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Bromocriptine—type 2 diabetes mellitus	3.82e-05	0.000296	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Bromocriptine—type 2 diabetes mellitus	3.81e-05	0.000296	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Irbesartan—type 2 diabetes mellitus	3.81e-05	0.000295	CcSEcCtD
Medroxyprogesterone Acetate—Tension—Ramipril—type 2 diabetes mellitus	3.81e-05	0.000295	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Losartan—type 2 diabetes mellitus	3.8e-05	0.000295	CcSEcCtD
Medroxyprogesterone Acetate—Dysgeusia—Ramipril—type 2 diabetes mellitus	3.8e-05	0.000294	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	3.79e-05	0.000294	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Bromocriptine—type 2 diabetes mellitus	3.79e-05	0.000294	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	3.79e-05	0.000294	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Glyburide—type 2 diabetes mellitus	3.79e-05	0.000293	CcSEcCtD
Medroxyprogesterone Acetate—Nervousness—Ramipril—type 2 diabetes mellitus	3.77e-05	0.000292	CcSEcCtD
Medroxyprogesterone Acetate—Dry mouth—Losartan—type 2 diabetes mellitus	3.77e-05	0.000292	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Irbesartan—type 2 diabetes mellitus	3.74e-05	0.00029	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	3.73e-05	0.000289	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Metformin—type 2 diabetes mellitus	3.73e-05	0.000289	CcSEcCtD
Medroxyprogesterone Acetate—Muscle spasms—Ramipril—type 2 diabetes mellitus	3.73e-05	0.000289	CcSEcCtD
Medroxyprogesterone Acetate—Confusional state—Losartan—type 2 diabetes mellitus	3.72e-05	0.000289	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Orlistat—type 2 diabetes mellitus	3.72e-05	0.000288	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Metformin—type 2 diabetes mellitus	3.71e-05	0.000287	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Metformin—type 2 diabetes mellitus	3.69e-05	0.000286	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Losartan—type 2 diabetes mellitus	3.69e-05	0.000286	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Losartan—type 2 diabetes mellitus	3.69e-05	0.000286	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	3.69e-05	0.000286	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Losartan—type 2 diabetes mellitus	3.67e-05	0.000284	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Irbesartan—type 2 diabetes mellitus	3.67e-05	0.000284	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	3.66e-05	0.000284	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Metformin—type 2 diabetes mellitus	3.66e-05	0.000284	CcSEcCtD
Medroxyprogesterone Acetate—Tremor—Ramipril—type 2 diabetes mellitus	3.63e-05	0.000282	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Losartan—type 2 diabetes mellitus	3.63e-05	0.000282	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Valsartan—type 2 diabetes mellitus	3.63e-05	0.000281	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Losartan—type 2 diabetes mellitus	3.62e-05	0.000281	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Losartan—type 2 diabetes mellitus	3.61e-05	0.00028	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Metformin—type 2 diabetes mellitus	3.61e-05	0.00028	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Valsartan—type 2 diabetes mellitus	3.61e-05	0.00028	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Losartan—type 2 diabetes mellitus	3.6e-05	0.000279	CcSEcCtD
Medroxyprogesterone Acetate—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	3.6e-05	0.000279	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Bromocriptine—type 2 diabetes mellitus	3.59e-05	0.000279	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	3.59e-05	0.000278	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Metformin—type 2 diabetes mellitus	3.58e-05	0.000278	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Orlistat—type 2 diabetes mellitus	3.58e-05	0.000278	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	3.57e-05	0.000277	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Losartan—type 2 diabetes mellitus	3.57e-05	0.000277	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Orlistat—type 2 diabetes mellitus	3.57e-05	0.000276	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Orlistat—type 2 diabetes mellitus	3.57e-05	0.000276	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Gliclazide—type 2 diabetes mellitus	3.56e-05	0.000276	CcSEcCtD
Medroxyprogesterone Acetate—Agitation—Ramipril—type 2 diabetes mellitus	3.56e-05	0.000276	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Metformin—type 2 diabetes mellitus	3.55e-05	0.000276	CcSEcCtD
Medroxyprogesterone Acetate—Angioedema—Ramipril—type 2 diabetes mellitus	3.54e-05	0.000275	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Irbesartan—type 2 diabetes mellitus	3.52e-05	0.000273	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Losartan—type 2 diabetes mellitus	3.52e-05	0.000273	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Glyburide—type 2 diabetes mellitus	3.52e-05	0.000273	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Gliclazide—type 2 diabetes mellitus	3.51e-05	0.000272	CcSEcCtD
Medroxyprogesterone Acetate—Malaise—Ramipril—type 2 diabetes mellitus	3.5e-05	0.000271	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Irbesartan—type 2 diabetes mellitus	3.5e-05	0.000271	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Glyburide—type 2 diabetes mellitus	3.49e-05	0.00027	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Irbesartan—type 2 diabetes mellitus	3.49e-05	0.00027	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Glyburide—type 2 diabetes mellitus	3.48e-05	0.00027	CcSEcCtD
Medroxyprogesterone Acetate—Vertigo—Ramipril—type 2 diabetes mellitus	3.48e-05	0.00027	CcSEcCtD
Medroxyprogesterone Acetate—Syncope—Ramipril—type 2 diabetes mellitus	3.48e-05	0.00027	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Glyburide—type 2 diabetes mellitus	3.47e-05	0.000269	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Irbesartan—type 2 diabetes mellitus	3.45e-05	0.000268	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Losartan—type 2 diabetes mellitus	3.45e-05	0.000267	CcSEcCtD
Medroxyprogesterone Acetate—Palpitations—Ramipril—type 2 diabetes mellitus	3.43e-05	0.000266	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Metformin—type 2 diabetes mellitus	3.42e-05	0.000266	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Irbesartan—type 2 diabetes mellitus	3.41e-05	0.000264	CcSEcCtD
Medroxyprogesterone Acetate—Loss of consciousness—Ramipril—type 2 diabetes mellitus	3.41e-05	0.000264	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Gliclazide—type 2 diabetes mellitus	3.4e-05	0.000263	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	3.4e-05	0.000263	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	3.39e-05	0.000263	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Irbesartan—type 2 diabetes mellitus	3.38e-05	0.000262	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	3.36e-05	0.000261	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Valsartan—type 2 diabetes mellitus	3.36e-05	0.000261	CcSEcCtD
Medroxyprogesterone Acetate—Convulsion—Ramipril—type 2 diabetes mellitus	3.36e-05	0.00026	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Irbesartan—type 2 diabetes mellitus	3.35e-05	0.00026	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Losartan—type 2 diabetes mellitus	3.34e-05	0.000259	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Orlistat—type 2 diabetes mellitus	3.32e-05	0.000258	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Losartan—type 2 diabetes mellitus	3.31e-05	0.000257	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Metformin—type 2 diabetes mellitus	3.3e-05	0.000256	CcSEcCtD
Medroxyprogesterone Acetate—Chest pain—Ramipril—type 2 diabetes mellitus	3.3e-05	0.000256	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Ramipril—type 2 diabetes mellitus	3.3e-05	0.000256	CcSEcCtD
Medroxyprogesterone Acetate—Arthralgia—Ramipril—type 2 diabetes mellitus	3.3e-05	0.000256	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Losartan—type 2 diabetes mellitus	3.29e-05	0.000255	CcSEcCtD
Medroxyprogesterone Acetate—Anxiety—Ramipril—type 2 diabetes mellitus	3.29e-05	0.000255	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Glyburide—type 2 diabetes mellitus	3.29e-05	0.000255	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Metformin—type 2 diabetes mellitus	3.29e-05	0.000255	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Gliclazide—type 2 diabetes mellitus	3.28e-05	0.000255	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Losartan—type 2 diabetes mellitus	3.28e-05	0.000254	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	3.28e-05	0.000254	CcSEcCtD
Medroxyprogesterone Acetate—Progesterone—NR3C1—type 2 diabetes mellitus	3.27e-05	0.00966	CrCbGaD
Medroxyprogesterone Acetate—Asthenia—Valsartan—type 2 diabetes mellitus	3.27e-05	0.000254	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Ramipril—type 2 diabetes mellitus	3.26e-05	0.000253	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Losartan—type 2 diabetes mellitus	3.25e-05	0.000252	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Orlistat—type 2 diabetes mellitus	3.24e-05	0.000251	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	3.23e-05	0.000251	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Valsartan—type 2 diabetes mellitus	3.23e-05	0.00025	CcSEcCtD
Medroxyprogesterone Acetate—Dry mouth—Ramipril—type 2 diabetes mellitus	3.23e-05	0.00025	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Losartan—type 2 diabetes mellitus	3.21e-05	0.000249	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	3.21e-05	0.000249	CcSEcCtD
Medroxyprogesterone Acetate—Confusional state—Ramipril—type 2 diabetes mellitus	3.19e-05	0.000247	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Orlistat—type 2 diabetes mellitus	3.19e-05	0.000247	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Losartan—type 2 diabetes mellitus	3.18e-05	0.000247	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	3.17e-05	0.000245	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Ramipril—type 2 diabetes mellitus	3.17e-05	0.000245	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Gliclazide—type 2 diabetes mellitus	3.16e-05	0.000245	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Losartan—type 2 diabetes mellitus	3.16e-05	0.000245	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Gliclazide—type 2 diabetes mellitus	3.13e-05	0.000243	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Gliclazide—type 2 diabetes mellitus	3.13e-05	0.000243	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Valsartan—type 2 diabetes mellitus	3.12e-05	0.000242	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Irbesartan—type 2 diabetes mellitus	3.12e-05	0.000242	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Ramipril—type 2 diabetes mellitus	3.11e-05	0.000241	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Gliclazide—type 2 diabetes mellitus	3.11e-05	0.000241	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Ramipril—type 2 diabetes mellitus	3.1e-05	0.000241	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Irbesartan—type 2 diabetes mellitus	3.1e-05	0.00024	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Irbesartan—type 2 diabetes mellitus	3.1e-05	0.00024	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	3.1e-05	0.00024	CcSEcCtD
Medroxyprogesterone Acetate—Methyltestosterone—CYP3A4—type 2 diabetes mellitus	3.09e-05	0.00913	CrCbGaD
Medroxyprogesterone Acetate—Tachycardia—Ramipril—type 2 diabetes mellitus	3.09e-05	0.000239	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Orlistat—type 2 diabetes mellitus	3.09e-05	0.000239	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Ramipril—type 2 diabetes mellitus	3.07e-05	0.000238	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	3.06e-05	0.000237	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Losartan—type 2 diabetes mellitus	3.04e-05	0.000236	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	3.02e-05	0.000234	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Valsartan—type 2 diabetes mellitus	3.02e-05	0.000234	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Ramipril—type 2 diabetes mellitus	3.02e-05	0.000234	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Orlistat—type 2 diabetes mellitus	2.98e-05	0.000231	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Metformin—type 2 diabetes mellitus	2.98e-05	0.000231	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Ramipril—type 2 diabetes mellitus	2.96e-05	0.000229	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Gliclazide—type 2 diabetes mellitus	2.95e-05	0.000229	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Metformin—type 2 diabetes mellitus	2.94e-05	0.000228	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Losartan—type 2 diabetes mellitus	2.93e-05	0.000227	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Losartan—type 2 diabetes mellitus	2.92e-05	0.000226	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Losartan—type 2 diabetes mellitus	2.92e-05	0.000226	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Valsartan—type 2 diabetes mellitus	2.9e-05	0.000225	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	2.89e-05	0.000224	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	2.88e-05	0.000224	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Valsartan—type 2 diabetes mellitus	2.88e-05	0.000223	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Valsartan—type 2 diabetes mellitus	2.88e-05	0.000223	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Orlistat—type 2 diabetes mellitus	2.87e-05	0.000222	CcSEcCtD
Medroxyprogesterone Acetate—Progesterone—CYP1A2—type 2 diabetes mellitus	2.87e-05	0.00846	CrCbGaD
Medroxyprogesterone Acetate—Insomnia—Ramipril—type 2 diabetes mellitus	2.86e-05	0.000222	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Valsartan—type 2 diabetes mellitus	2.86e-05	0.000222	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Metformin—type 2 diabetes mellitus	2.84e-05	0.00022	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Orlistat—type 2 diabetes mellitus	2.84e-05	0.00022	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Ramipril—type 2 diabetes mellitus	2.84e-05	0.00022	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Orlistat—type 2 diabetes mellitus	2.84e-05	0.00022	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Orlistat—type 2 diabetes mellitus	2.83e-05	0.000219	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Ramipril—type 2 diabetes mellitus	2.82e-05	0.000219	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Irbesartan—type 2 diabetes mellitus	2.81e-05	0.000218	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Ramipril—type 2 diabetes mellitus	2.81e-05	0.000218	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Ramipril—type 2 diabetes mellitus	2.79e-05	0.000216	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Irbesartan—type 2 diabetes mellitus	2.77e-05	0.000215	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Ramipril—type 2 diabetes mellitus	2.75e-05	0.000213	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Metformin—type 2 diabetes mellitus	2.75e-05	0.000213	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	2.73e-05	0.000212	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Ramipril—type 2 diabetes mellitus	2.73e-05	0.000212	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Losartan—type 2 diabetes mellitus	2.72e-05	0.000211	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Valsartan—type 2 diabetes mellitus	2.71e-05	0.00021	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Ramipril—type 2 diabetes mellitus	2.71e-05	0.00021	CcSEcCtD
Medroxyprogesterone Acetate—Methyltestosterone—ALB—type 2 diabetes mellitus	2.7e-05	0.00796	CrCbGaD
Medroxyprogesterone Acetate—Diarrhoea—Irbesartan—type 2 diabetes mellitus	2.68e-05	0.000208	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Orlistat—type 2 diabetes mellitus	2.68e-05	0.000208	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Losartan—type 2 diabetes mellitus	2.65e-05	0.000205	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Metformin—type 2 diabetes mellitus	2.64e-05	0.000205	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Metformin—type 2 diabetes mellitus	2.62e-05	0.000203	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Metformin—type 2 diabetes mellitus	2.62e-05	0.000203	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Losartan—type 2 diabetes mellitus	2.61e-05	0.000202	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Ramipril—type 2 diabetes mellitus	2.61e-05	0.000202	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Metformin—type 2 diabetes mellitus	2.6e-05	0.000202	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Irbesartan—type 2 diabetes mellitus	2.59e-05	0.000201	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	2.59e-05	0.000201	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Losartan—type 2 diabetes mellitus	2.53e-05	0.000196	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Ramipril—type 2 diabetes mellitus	2.51e-05	0.000195	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Ramipril—type 2 diabetes mellitus	2.5e-05	0.000194	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Ramipril—type 2 diabetes mellitus	2.5e-05	0.000194	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Irbesartan—type 2 diabetes mellitus	2.49e-05	0.000193	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Irbesartan—type 2 diabetes mellitus	2.47e-05	0.000192	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Irbesartan—type 2 diabetes mellitus	2.47e-05	0.000192	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Metformin—type 2 diabetes mellitus	2.47e-05	0.000191	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Irbesartan—type 2 diabetes mellitus	2.46e-05	0.00019	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Losartan—type 2 diabetes mellitus	2.44e-05	0.000189	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Losartan—type 2 diabetes mellitus	2.35e-05	0.000182	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Ramipril—type 2 diabetes mellitus	2.33e-05	0.000181	CcSEcCtD
Medroxyprogesterone Acetate—Hydrocortisone—CYP3A4—type 2 diabetes mellitus	2.33e-05	0.00688	CrCbGaD
Medroxyprogesterone Acetate—Nausea—Irbesartan—type 2 diabetes mellitus	2.33e-05	0.000181	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Losartan—type 2 diabetes mellitus	2.33e-05	0.00018	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Losartan—type 2 diabetes mellitus	2.33e-05	0.00018	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Losartan—type 2 diabetes mellitus	2.31e-05	0.000179	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Ramipril—type 2 diabetes mellitus	2.27e-05	0.000176	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Ramipril—type 2 diabetes mellitus	2.24e-05	0.000174	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Losartan—type 2 diabetes mellitus	2.19e-05	0.00017	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Ramipril—type 2 diabetes mellitus	2.17e-05	0.000168	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Ramipril—type 2 diabetes mellitus	2.09e-05	0.000162	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Ramipril—type 2 diabetes mellitus	2.01e-05	0.000156	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Ramipril—type 2 diabetes mellitus	2e-05	0.000155	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Ramipril—type 2 diabetes mellitus	1.99e-05	0.000155	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Ramipril—type 2 diabetes mellitus	1.98e-05	0.000154	CcSEcCtD
Medroxyprogesterone Acetate—Progesterone—CYP3A4—type 2 diabetes mellitus	1.9e-05	0.0056	CrCbGaD
Medroxyprogesterone Acetate—Nausea—Ramipril—type 2 diabetes mellitus	1.88e-05	0.000146	CcSEcCtD
Medroxyprogesterone Acetate—Testosterone—CYP3A4—type 2 diabetes mellitus	1.79e-05	0.0053	CrCbGaD
Medroxyprogesterone Acetate—Testosterone—ALB—type 2 diabetes mellitus	1.57e-05	0.00462	CrCbGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—HSD3B2—type 2 diabetes mellitus	4.15e-06	5.6e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—KCNJ11—type 2 diabetes mellitus	4.15e-06	5.6e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GCKR—type 2 diabetes mellitus	4.15e-06	5.6e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	4.11e-06	5.55e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.08e-06	5.51e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—NAMPT—type 2 diabetes mellitus	4.07e-06	5.5e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	4.05e-06	5.47e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—HBA1—type 2 diabetes mellitus	4.05e-06	5.46e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—LIPC—type 2 diabetes mellitus	4.05e-06	5.46e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—GCK—type 2 diabetes mellitus	4.05e-06	5.46e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CYP11A1—type 2 diabetes mellitus	4.02e-06	5.43e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.01e-06	5.42e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.01e-06	5.41e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	3.99e-06	5.38e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ALDOB—type 2 diabetes mellitus	3.98e-06	5.37e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—SLC9A1—type 2 diabetes mellitus	3.95e-06	5.33e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.92e-06	5.29e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CETP—type 2 diabetes mellitus	3.91e-06	5.27e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	3.88e-06	5.24e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	3.88e-06	5.24e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	3.86e-06	5.21e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—PPARG—type 2 diabetes mellitus	3.82e-06	5.15e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.81e-06	5.14e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	3.78e-06	5.11e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	3.78e-06	5.11e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	3.77e-06	5.09e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—PPARG—type 2 diabetes mellitus	3.76e-06	5.08e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	3.74e-06	5.05e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—GNB3—type 2 diabetes mellitus	3.74e-06	5.04e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.7e-06	5e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GLP1R—type 2 diabetes mellitus	3.7e-06	4.99e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—MMP3—type 2 diabetes mellitus	3.69e-06	4.97e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—AVP—type 2 diabetes mellitus	3.69e-06	4.97e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IGF2—type 2 diabetes mellitus	3.67e-06	4.95e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.66e-06	4.94e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	3.65e-06	4.93e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	3.64e-06	4.91e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.64e-06	4.91e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.64e-06	4.91e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—SREBF1—type 2 diabetes mellitus	3.63e-06	4.9e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—SNAP25—type 2 diabetes mellitus	3.63e-06	4.9e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PSMD6—type 2 diabetes mellitus	3.63e-06	4.9e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	3.61e-06	4.87e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	3.61e-06	4.87e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	3.61e-06	4.87e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CTGF—type 2 diabetes mellitus	3.56e-06	4.81e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—APOB—type 2 diabetes mellitus	3.56e-06	4.81e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	3.55e-06	4.79e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—HMGCR—type 2 diabetes mellitus	3.53e-06	4.77e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—EDN1—type 2 diabetes mellitus	3.51e-06	4.73e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	3.48e-06	4.7e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	3.46e-06	4.67e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	3.46e-06	4.67e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—ADRA2A—type 2 diabetes mellitus	3.46e-06	4.66e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—SLC2A2—type 2 diabetes mellitus	3.45e-06	4.66e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—SERPINE1—type 2 diabetes mellitus	3.44e-06	4.64e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—RELA—type 2 diabetes mellitus	3.43e-06	4.62e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—SRC—type 2 diabetes mellitus	3.41e-06	4.61e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—LPL—type 2 diabetes mellitus	3.4e-06	4.59e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—SERPINE1—type 2 diabetes mellitus	3.39e-06	4.57e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CPT1A—type 2 diabetes mellitus	3.38e-06	4.56e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—MTR—type 2 diabetes mellitus	3.38e-06	4.56e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	3.33e-06	4.49e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	3.33e-06	4.49e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	3.33e-06	4.49e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.32e-06	4.49e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CYP2E1—type 2 diabetes mellitus	3.32e-06	4.48e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—NAMPT—type 2 diabetes mellitus	3.32e-06	4.47e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	3.3e-06	4.45e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	3.3e-06	4.45e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	3.3e-06	4.45e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	3.3e-06	4.45e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CYP1A2—type 2 diabetes mellitus	3.28e-06	4.43e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—SLC2A1—type 2 diabetes mellitus	3.28e-06	4.43e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—IL6—type 2 diabetes mellitus	3.28e-06	4.43e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	3.27e-06	4.42e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	3.27e-06	4.42e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	3.22e-06	4.34e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	3.22e-06	4.34e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	3.22e-06	4.34e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	3.22e-06	4.34e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CYP3A4—type 2 diabetes mellitus	3.2e-06	4.32e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	3.19e-06	4.31e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.19e-06	4.3e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	3.18e-06	4.29e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—GCG—type 2 diabetes mellitus	3.15e-06	4.25e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—SLC2A4—type 2 diabetes mellitus	3.15e-06	4.25e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CCR5—type 2 diabetes mellitus	3.13e-06	4.23e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.09e-06	4.17e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—C3—type 2 diabetes mellitus	3.06e-06	4.13e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.05e-06	4.12e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—AKT1—type 2 diabetes mellitus	3.03e-06	4.09e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	3.03e-06	4.08e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.99e-06	4.04e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	2.96e-06	4e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	2.96e-06	3.99e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	2.96e-06	3.99e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	2.96e-06	3.99e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.92e-06	3.94e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.92e-06	3.94e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.91e-06	3.93e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—AGT—type 2 diabetes mellitus	2.91e-06	3.93e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	2.9e-06	3.91e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.89e-06	3.9e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	2.88e-06	3.88e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.86e-06	3.86e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—LEP—type 2 diabetes mellitus	2.85e-06	3.85e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—APOE—type 2 diabetes mellitus	2.85e-06	3.85e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	2.84e-06	3.83e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	2.83e-06	3.82e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.82e-06	3.8e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	2.81e-06	3.8e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	2.74e-06	3.69e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	2.74e-06	3.69e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	2.74e-06	3.69e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	2.74e-06	3.69e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—GNB3—type 2 diabetes mellitus	2.71e-06	3.66e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.71e-06	3.66e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	2.7e-06	3.65e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—HMOX1—type 2 diabetes mellitus	2.7e-06	3.65e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—SRC—type 2 diabetes mellitus	2.69e-06	3.63e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.69e-06	3.63e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	2.67e-06	3.61e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	2.67e-06	3.61e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CAT—type 2 diabetes mellitus	2.67e-06	3.6e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	2.62e-06	3.54e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.62e-06	3.54e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	2.61e-06	3.52e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	2.59e-06	3.5e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—APOB—type 2 diabetes mellitus	2.59e-06	3.49e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—AKT1—type 2 diabetes mellitus	2.57e-06	3.47e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	2.56e-06	3.46e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	2.56e-06	3.46e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.54e-06	3.43e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—AKT1—type 2 diabetes mellitus	2.54e-06	3.42e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—GSTM1—type 2 diabetes mellitus	2.52e-06	3.4e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—LPL—type 2 diabetes mellitus	2.47e-06	3.33e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	2.44e-06	3.29e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—INS—type 2 diabetes mellitus	2.44e-06	3.29e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—ADCY5—type 2 diabetes mellitus	2.42e-06	3.26e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—GPX1—type 2 diabetes mellitus	2.41e-06	3.25e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.41e-06	3.25e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.4e-06	3.23e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.36e-06	3.18e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.36e-06	3.18e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.35e-06	3.18e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CD36—type 2 diabetes mellitus	2.35e-06	3.17e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PPP2CA—type 2 diabetes mellitus	2.32e-06	3.13e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—IL6—type 2 diabetes mellitus	2.3e-06	3.1e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	2.28e-06	3.07e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.24e-06	3.02e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	2.23e-06	3.01e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	2.23e-06	3.01e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—MTHFR—type 2 diabetes mellitus	2.22e-06	3e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.21e-06	2.98e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	2.21e-06	2.98e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	2.2e-06	2.97e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	2.19e-06	2.95e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PPARA—type 2 diabetes mellitus	2.18e-06	2.94e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	2.17e-06	2.93e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	2.17e-06	2.93e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	2.17e-06	2.93e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	2.17e-06	2.93e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	2.16e-06	2.91e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.14e-06	2.88e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.14e-06	2.88e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	2.12e-06	2.86e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.12e-06	2.86e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—AGT—type 2 diabetes mellitus	2.11e-06	2.85e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	2.11e-06	2.84e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	2.1e-06	2.83e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CALM1—type 2 diabetes mellitus	2.08e-06	2.8e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—APOE—type 2 diabetes mellitus	2.07e-06	2.79e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	2.05e-06	2.76e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—APOA1—type 2 diabetes mellitus	2.05e-06	2.76e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	2.01e-06	2.71e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—RELA—type 2 diabetes mellitus	2.01e-06	2.71e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	1.97e-06	2.66e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	1.96e-06	2.65e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—AKT1—type 2 diabetes mellitus	1.96e-06	2.65e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	1.95e-06	2.63e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	1.95e-06	2.63e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	1.95e-06	2.63e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	1.91e-06	2.58e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	1.91e-06	2.58e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	1.9e-06	2.56e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	1.89e-06	2.55e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	1.86e-06	2.5e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.81e-06	2.45e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—IL6—type 2 diabetes mellitus	1.81e-06	2.45e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	1.81e-06	2.44e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	1.8e-06	2.43e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	1.78e-06	2.41e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	1.78e-06	2.4e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	1.77e-06	2.39e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	1.76e-06	2.38e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	1.76e-06	2.38e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	1.72e-06	2.32e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.71e-06	2.31e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.7e-06	2.29e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	1.69e-06	2.28e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	1.69e-06	2.28e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	1.69e-06	2.28e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	1.69e-06	2.27e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.67e-06	2.26e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	1.67e-06	2.25e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	1.62e-06	2.19e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.58e-06	2.13e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	1.55e-06	2.09e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	1.55e-06	2.09e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.54e-06	2.08e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—AKT1—type 2 diabetes mellitus	1.51e-06	2.04e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—AKT1—type 2 diabetes mellitus	1.49e-06	2.01e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	1.47e-06	1.98e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.46e-06	1.97e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	1.46e-06	1.97e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	1.45e-06	1.96e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	1.44e-06	1.94e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	1.43e-06	1.93e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	1.42e-06	1.91e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.41e-06	1.91e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	1.39e-06	1.87e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.39e-06	1.87e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	1.35e-06	1.82e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	1.33e-06	1.79e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	1.32e-06	1.78e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.3e-06	1.75e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.29e-06	1.75e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	1.26e-06	1.7e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	1.26e-06	1.7e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.26e-06	1.7e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.24e-06	1.68e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.19e-06	1.61e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.17e-06	1.58e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	1.16e-06	1.56e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.13e-06	1.53e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.12e-06	1.51e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.11e-06	1.5e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.1e-06	1.48e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.06e-06	1.44e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.82e-07	1.33e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	9.68e-07	1.31e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	9.5e-07	1.28e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	8.71e-07	1.17e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	8.33e-07	1.12e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	8.33e-07	1.12e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	7.62e-07	1.03e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	7.13e-07	9.62e-06	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	5.8e-07	7.83e-06	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	3.83e-07	5.17e-06	CbGpPWpGaD
